GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
01:09 Mar 24, 2011 |
English to French translations [PRO] Bus/Financial - Law: Patents, Trademarks, Copyright / Patent position | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Marion RIHANI Local time: 23:02 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
3 +2 | portefeuille de brevets |
| ||
3 | la situation de ses brevets |
|
Summary of reference entries provided | |||
---|---|---|---|
For reference and examples |
|
patent position la situation de ses brevets Explanation: ou: sa position dans le domaine des brevets (relatifs à tel produit) |
| |
Login to enter a peer comment (or grade) |
patent position portefeuille de brevets Explanation: the patents owned worldwide. |
| |||||||||
Grading comment
| ||||||||||
|
8 hrs |
Reference: For reference and examples Reference information: http://www.proz.com/kudoz/english_to_french/law:_patents_tra... IPSOGEN Strengthens its Patent Position with U.S. Allowance of Additional JAK2 V617F Claims IPSOGEN (Alternext - FR0010626028 - ALIPS) announced today that the United States Patent and Trademark Office (USPTO) has allowed claims that strengthen the company’s patent position for the detection and diagnostic use of the JAK2 V617F mutation. http://www.ipsogen.com/en/press-releases/press-release/artic... IPSOGEN renforce sa position en matière de brevets sur la technologie JAK2 aux Etats-Unis IPSOGEN (Alternext - FR0010626028 - ALIPS) annonce aujourd’hui que l’office de brevets et marques Américain (USPTO) lui a accordé des revendications additionnelles qui renforcent la position de la société en matière de brevets dans le domaine de la détection et de l’utilisation de la mutation JAK2 V617F à des fins diagnostiques. http://www.ipsogen.com/fr/communiques-de-presse/communique-d... -------------------------------------------------- Note added at 11 hrs (2011-03-24 12:53:39 GMT) -------------------------------------------------- position/portefeuille (44) Les autres compagnies pétrolières et gazières disposent de portefeuilles de brevets limités pour l'un ou l'autre procédé, voire pour les deux. Toutefois, aucune de ces compagnies n'est en mesure de traiter toutes les étapes essentielles de l'une ou de l'autre filière. (45) Sous l'angle des brevets, les positions respectives d'Exxon et de Mobil correspondent actuellement à des variantes, mais qui ne sont pas interchangeables. À l'issue de la concentration, la position forte des parties en matière de brevets aurait un effet dissuasif sur les nouveaux venus potentiels. Enfin, les ressources financières substantielles nécessaires pour concurrencer le GTL (ainsi, par exemple, la construction d'une usine «F-T» coûte actuellement [de 1 à 3]* milliards d'USD) empêcheraient à la fois l'expansion des entreprises existantes et l'entrée de concurrents potentiels sur le marché. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2... (44) Other oil and gas companies have limited patent positions in one or the other, or sometimes both, processes. However, none of these companies have positions that cover all of the essential steps of either pathway. (45) The patent positions of Exxon and Mobil currently represent alternative, although not substitutable, positions. Post-merger, the strong patent position of the parties would create disincentives to any potential new entrant. Finally, the substantial financial resources necessary to compete in GTL (for example: currently a F-T plant costs [between USD 1 and 3]* billion to build) would prevent both expansion by incumbents and entry by potential competitors. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2... |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.